Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,200Revenue $M30.7Net Margin (%)-282.7Altman Z-Score47.1
Enterprise Value $M2,873EPS $-0.4Operating Margin %-283.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-282.7Higher ROA y-yY
Price/Book7.810-y EBITDA Growth Rate %-0.6Quick Ratio12.2Cash flow > EarningsY
Price/Sales84.55-y EBITDA Growth Rate %-3.8Current Ratio12.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-30.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-34.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M268ROIC % (ttm)-108.4Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVAXFirst Eagle Investment 2014-12-31 Sold Out -0.01%$4.05 - $5.98
$ 11.94128%Sold Out0
NVAXFirst Eagle Investment 2014-06-30 Add$3.69 - $5.13
$ 11.94172%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
$ 11.94114%Sold Out0
NVAXFirst Eagle Investment 2014-03-31 Reduce-0.01%$4.13 - $6.65
$ 11.94114%Reduce 75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
$ 11.94240%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
$ 11.94240%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
$ 11.94323%New holding573,000
NVAXFirst Eagle Investment 2013-09-30 Buy 0.01%$2.25 - $3.39
$ 11.94323%New holding800,000
NVAXFirst Eagle Investment 2011-03-31 Sold Out $2.15 - $2.96
$ 11.94389%Sold Out0
NVAXFirst Eagle Investment 2010-09-30 Add$2.01 - $2.34
$ 11.94443%Add 25.00%125,000
NVAXFirst Eagle Investment 2010-06-30 Reduce$2.18 - $2.97
$ 11.94385%Reduce 52.65%100,000
NVAXFirst Eagle Investment 2009-12-31 Buy 0.01%$2.53 - $4.41
$ 11.94245%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
YOUNG JAMES FDirector 2015-06-18Sell50,000$9.4726.08 view
Modi Rajiv I.Director 2015-06-17Sell433,053$9.0132.52 view
Modi Rajiv I.Director 2015-06-11Sell11,185$932.67 view
Modi Rajiv I.Director 2015-06-10Sell551,081$8.9733.11 view
Modi Rajiv I.Director 2015-06-04Sell504,681$8.9233.86 view
Modi Rajiv I.Director 2015-06-01Sell3,500,000$8.7436.61 view
Herrmann John A IIISVP, General Counsel 2015-01-31Buy9,869$2.28423.68 view
Hahn Timothy JonSVP, Manufacturing 2015-01-31Buy9,329$2.28423.68 view
Wilson Russell PSVP, Business Development 2015-01-31Buy5,050$2.28423.68 view
Glenn Gregory MSVP, Research and Development 2015-01-31Buy866$2.28423.68 view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
comment on NVAX Mar 16 2013 
comment on NVAX Mar 16 2013 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
creiter note on NVAX Jan 03 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 

More From Other Websites
5 stocks to watch Jul 29 2015
Ebola threat not over yet, survivor says Jul 21 2015
Does Novavax Have the Answer for Ebola in New Trial? Jul 21 2015
Novavax Ebola Vaccine Shows Human Immune Response in Early Trial Jul 21 2015
Novavax rises on promising Ebola vaccine trial Jul 21 2015
Novavax Announces Positive Top-Line Data From Phase 1 Ebola Vaccine Trial on WHO Teleconference Jul 21 2015
Novavax's Ebola vaccine shows promise in early-stage trial Jul 21 2015
Novavax Ebola Vaccine Shows Human Immune Response in Early Trial Jul 21 2015
Six stocks to watch Jul 15 2015
Novavax (NVAX) Looks Good: Stock Moves 11% Higher - Tale of the Tape Jul 10 2015
6 stocks to watch Jun 24 2015
Strength Seen in Novavax (NVAX): Stock Gains 11.6% - Tale of the Tape Jun 24 2015
Novavax, Inc. (NVAX) Up Again And 90% In 2015: Is It Too Late To Board This Gravy Train? Jun 24 2015
Novavax extends gains, hits highest since 2002 Jun 23 2015
Can The Uptrend Continue for Novavax (NVAX)? - Tale of the Tape Jun 23 2015
NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 19 2015
Biotech bargain bin Jun 19 2015
Novavax Recognized by Washington Post as Top Workplace Jun 19 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)